Anniken Hagen
Plus aucun poste en cours
Profil
Anniken Hagen formerly worked at Pronova Biomedical AS, as Scientist, Algeta ASA, as Manager-Quality Control, Oslo universitetssykehus HF, as Head-Quality Assurance, and Nordic Nanovector ASA, as Co-COO & Chief Technical Officer.
Ms. Hagen received her graduate degree from the University of Oslo.
Anciens postes connus de Anniken Hagen
| Sociétés | Poste | Fin |
|---|---|---|
Oslo universitetssykehus HF
 Oslo universitetssykehus HF Hospital/Nursing ManagementHealth Services Oslo universitetssykehus HF operates local hospital, acute hospitals, and regional hospital for residents and has a number of national tasks. It carries out patient treatment, research, and trial treatments, gives advice and provides education. The company was founded on December 1, 2008 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | - |
| ALGETA ASA | Corporate Officer/Principal | - |
Pronova Biomedical AS
 Pronova Biomedical AS Pharmaceuticals: OtherHealth Technology Part of FMC Corp., Pronova Biomedical AS is a provider of ultra-pure alginates and chitosans to the pharmaceutical and medical materials markets. Pronova Biomedical was acquired by FMC BioPolymer, Inc. from Norsk Hydro ASA on January 15, 2002. | Directeur Technique/Scientifique/R&D | - |
| THOR MEDICAL | Directeur des opérations | - |
Formation de Anniken Hagen
| University of Oslo | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Pronova Biomedical AS
Pronova Biomedical AS Pharmaceuticals: OtherHealth Technology Part of FMC Corp., Pronova Biomedical AS is a provider of ultra-pure alginates and chitosans to the pharmaceutical and medical materials markets. Pronova Biomedical was acquired by FMC BioPolymer, Inc. from Norsk Hydro ASA on January 15, 2002. | Health Technology |
Oslo universitetssykehus HF
Oslo universitetssykehus HF Hospital/Nursing ManagementHealth Services Oslo universitetssykehus HF operates local hospital, acute hospitals, and regional hospital for residents and has a number of national tasks. It carries out patient treatment, research, and trial treatments, gives advice and provides education. The company was founded on December 1, 2008 and is headquartered in Oslo, Norway. | Health Services |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |